Fostering the development of AI-enhanced technologies to support healthy aging at home for older adults and individuals with Alzheimer’s disease.
Featured Pilots
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
Leveraging AI for Just-in-Time Smartphone Solutions for Family Caregivers
Investigators:
Felipe A. Jain, Massachusetts General Hospital
Finale Doshi-Velez, Harvard University
AI-Driven Drug Repurposing to Identify Potential Geroprotectors
Investigators:
Jesse Poganik, Brigham and Women’s Hospital
News & Events
-
Past Webinar – Best Practices for Digital Phenotyping Research in Aging PopulationsMay 14, 2026/0 Comments -
-
-
